Romanian biotech firm Norofert boosts profit 68% in H1 2025 despite slight revenue drop, citing cost control and strong farm and international performance.

Norofert, a Romanian biotechnology and organic agricultural inputs company, reported a 68% profit increase to RON3.2 million in the first half of 2025, despite a slight revenue decline to RON19 million. The company attributed improved profitability to cost control, in-house production, and strong performance from its Zimnicea farm and international operations. Its shares rose 5.4% year-to-date, with a market cap of RON65.18 million. The results reflect resilience in Romania’s agricultural tech sector amid broader economic challenges.